AAAAAA

   
Results: 1-19 |
Results: 19
CHEMOTAXINS C5A AND FMLP INDUCE RELEASE OF CALPROTECTIN (LEUKOCYTE L1PROTEIN) FROM POLYMORPHONUCLEAR CELLS IN-VITRO
Authors: HETLAND G TALGO GJ FAGERHOL MK
Citation: G. Hetland et al., CHEMOTAXINS C5A AND FMLP INDUCE RELEASE OF CALPROTECTIN (LEUKOCYTE L1PROTEIN) FROM POLYMORPHONUCLEAR CELLS IN-VITRO, Journal of clinical pathology-Molecular pathology, 51(3), 1998, pp. 143-148
INTESTINAL PERMEABILITY AND INFLAMMATION IN CROHNS-DISEASE AND THEIR FIRST DEGREE RELATIVES
Authors: THJODLEIFSSON B SIGTHORSSON G GUNNARSDOTTIR A NORLAND H ODDSSON E GUDJONSSON H EINARSSON S MEDDINGS J ROSETH A FAGERHOL MK CRANE R KJELD M BJARNASON I
Citation: B. Thjodleifsson et al., INTESTINAL PERMEABILITY AND INFLAMMATION IN CROHNS-DISEASE AND THEIR FIRST DEGREE RELATIVES, Gastroenterology, 114(4), 1998, pp. 4494-4494
FECAL CALPROTECTIN CONCENTRATION IN PATIENTS WITH COLORECTAL-CARCINOMA
Authors: KRISTINSSON J ROSETH A FAGERHOL MK AADLAND E SCHJONSBY H BORMER OP RAKNERUD N NYGAARD K
Citation: J. Kristinsson et al., FECAL CALPROTECTIN CONCENTRATION IN PATIENTS WITH COLORECTAL-CARCINOMA, Diseases of the colon & rectum, 41(3), 1998, pp. 316-321
FUNCTIONAL AND CLINICAL ASPECTS OF THE MYELOMONOCYTE PROTEIN CALPROTECTIN
Authors: JOHNE B FAGERHOL MK LYBERG T PRYDZ H BRANDTZAEG P NAESSANDRESEN CF DALE I
Citation: B. Johne et al., FUNCTIONAL AND CLINICAL ASPECTS OF THE MYELOMONOCYTE PROTEIN CALPROTECTIN, Journal of clinical pathology-Molecular pathology, 50(3), 1997, pp. 113-123
NOMENCLATURE FOR PROTEINS - IS CALPROTECTIN A PROPER NAME FOR THE ELUSIVE MYELOMONOCYTIC PROTEIN
Authors: FAGERHOL MK
Citation: Mk. Fagerhol, NOMENCLATURE FOR PROTEINS - IS CALPROTECTIN A PROPER NAME FOR THE ELUSIVE MYELOMONOCYTIC PROTEIN, JCP. Clinical molecular pathology, 49(2), 1996, pp. 74-79
GRANULOCYTE MARKER PROTEIN (GMP) IS ELEVATED IN STOOLS FROM RATS WITHAZOXYMETHANE-INDUCED COLON-CANCER AND ABERRANT CRYPTS
Authors: KRISTINSSON J ROSETH AG SUNDSET A NYGAARD K AADLAND E LOBERG EM PAULSEN JE FAGERHOL MK
Citation: J. Kristinsson et al., GRANULOCYTE MARKER PROTEIN (GMP) IS ELEVATED IN STOOLS FROM RATS WITHAZOXYMETHANE-INDUCED COLON-CANCER AND ABERRANT CRYPTS, Gastroenterology, 110(4), 1996, pp. 546-546
CALPROTECTIN - A NEVER PLASMA MARKER OF GRANULOCYTE ACTIVATION IN ACUTE CORONARY SYNDROME
Authors: ARVESEN K KONTNY F TOSS H WALLENTIN L ROSETH A SUNDSET A FAGERHOL MK
Citation: K. Arvesen et al., CALPROTECTIN - A NEVER PLASMA MARKER OF GRANULOCYTE ACTIVATION IN ACUTE CORONARY SYNDROME, Circulation, 94(8), 1996, pp. 3015-3015
CALPROTECTIN AS A MARKER OF INFLAMMATION IN CYSTIC-FIBROSIS
Authors: GOLDEN BE CLOHESSY PA RUSSELL G FAGERHOL MK
Citation: Be. Golden et al., CALPROTECTIN AS A MARKER OF INFLAMMATION IN CYSTIC-FIBROSIS, Archives of Disease in Childhood, 74(2), 1996, pp. 136-139
CALCIUM-BINDING AND CONCOMITANT CHANGES IN THE STRUCTURE AND HEAT-STABILITY OF CALPROTECTIN (L1 PROTEIN)
Authors: NAESSANDRESEN CF EGELANDSDAL B FAGERHOL MK
Citation: Cf. Naessandresen et al., CALCIUM-BINDING AND CONCOMITANT CHANGES IN THE STRUCTURE AND HEAT-STABILITY OF CALPROTECTIN (L1 PROTEIN), JCP. Clinical molecular pathology, 48(5), 1995, pp. 278-284
EFFECTS OF CALPROTECTIN IN AVRIDINE-INDUCED ARTHRITIS
Authors: BRUN JG HALAND G HAGA HJ FAGERHOL MK JONSSON R
Citation: Jg. Brun et al., EFFECTS OF CALPROTECTIN IN AVRIDINE-INDUCED ARTHRITIS, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 103(3), 1995, pp. 233-240
PLASMA CALPROTECTIN - A NEW PROGNOSTIC MARKER OF SURVIVAL IN ALCOHOL-INDUCED CIRRHOSIS
Authors: HOMANN C GARRED P GRAUDAL N HASSELQVIST P CHRISTIANSEN M FAGERHOL MK THOMSEN AC
Citation: C. Homann et al., PLASMA CALPROTECTIN - A NEW PROGNOSTIC MARKER OF SURVIVAL IN ALCOHOL-INDUCED CIRRHOSIS, Hepatology, 21(4), 1995, pp. 979-985
FECAL CALPROTECTIN IS ELEVATED IN PATIENTS WITH GASTRIC-CANCER
Authors: KRISTINSSON J ROSETH AG NYGAARD K AADLAND E FAGERHOL MK SCHJONSBY H
Citation: J. Kristinsson et al., FECAL CALPROTECTIN IS ELEVATED IN PATIENTS WITH GASTRIC-CANCER, Gastroenterology, 108(4), 1995, pp. 493-493
FECAL LACTOFERRIN, A NOVEL MARKER OF COLORECTAL-CANCER IN RATS, A LONGITUDINAL IN-VIVO STUDY
Authors: ROSETH AG KRISTINSSON J NYGAARD K AADLAND E SUNDSET A FAGERHOL MK
Citation: Ag. Roseth et al., FECAL LACTOFERRIN, A NOVEL MARKER OF COLORECTAL-CANCER IN RATS, A LONGITUDINAL IN-VIVO STUDY, Gastroenterology, 108(4), 1995, pp. 530-530
ELEVATED SERUM CALPROTECTIN LEVELS IN HIV-INFECTED PATIENTS - THE CALPROTECTIN RESPONSE DURING ZDV TREATMENT IS ASSOCIATED WITH CLINICAL EVENTS
Authors: MULLER F FROLAND SS AUKRUST P FAGERHOL MK
Citation: F. Muller et al., ELEVATED SERUM CALPROTECTIN LEVELS IN HIV-INFECTED PATIENTS - THE CALPROTECTIN RESPONSE DURING ZDV TREATMENT IS ASSOCIATED WITH CLINICAL EVENTS, Journal of acquired immune deficiency syndromes, 7(9), 1994, pp. 931-939
EFFECTS OF HUMAN CALPROTECTIN (L1) ON IN-VITRO IMMUNOGLOBULIN-SYNTHESIS
Authors: BRUN JG ULVESTAD E FAGERHOL MK JONSSON R
Citation: Jg. Brun et al., EFFECTS OF HUMAN CALPROTECTIN (L1) ON IN-VITRO IMMUNOGLOBULIN-SYNTHESIS, Scandinavian journal of immunology, 40(6), 1994, pp. 675-680
BIOCOMPATIBILITY OF HEPARIN-COATED CIRCUITS USED IN CARDIOPULMONARY BYPASS
Authors: PEKNA M BOROWIEC J FAGERHOL MK VENGE P THELIN S
Citation: M. Pekna et al., BIOCOMPATIBILITY OF HEPARIN-COATED CIRCUITS USED IN CARDIOPULMONARY BYPASS, Scandinavian journal of thoracic and cardiovascular surgery, 28(1), 1994, pp. 5-11
REDUCED COMPLEMENT AND GRANULOCYTE ACTIVATION WITH HEPARIN-COATED CARDIOPULMONARY BYPASS
Authors: FOSSE E MOEN O JOHNSON E SEMB G BROCKMEIER V MOLLNES TE FAGERHOL MK VENGE P
Citation: E. Fosse et al., REDUCED COMPLEMENT AND GRANULOCYTE ACTIVATION WITH HEPARIN-COATED CARDIOPULMONARY BYPASS, The Annals of thoracic surgery, 58(2), 1994, pp. 472-477
FECAL CALPROTECTIN - A NOVEL TEST FOR THE DIAGNOSIS OF COLORECTAL-CANCER
Authors: ROSETH AG KRISTINSSON J FAGERHOL MK SCHJONSBY H AADLAND E NYGAARD K ROALD B
Citation: Ag. Roseth et al., FECAL CALPROTECTIN - A NOVEL TEST FOR THE DIAGNOSIS OF COLORECTAL-CANCER, Scandinavian journal of gastroenterology, 28(12), 1993, pp. 1073-1076
CALPROTECTIN - A SENSITIVE MARKER OF GASTROINTESTINAL NEOPLASIA
Authors: ROSETH AG KRISTINSSON J AADLAND E SCHJONSBY H NYGAARD K FAGERHOL MK
Citation: Ag. Roseth et al., CALPROTECTIN - A SENSITIVE MARKER OF GASTROINTESTINAL NEOPLASIA, Gastroenterology, 104(4), 1993, pp. 445-445
Risultati: 1-19 |